Skip to main content
Log in

Evaluation of autonomic nervous system by salivary alpha-amylase level and heart rate variability in patients with schizophrenia

  • Short Communication
  • Published:
European Archives of Psychiatry and Clinical Neuroscience Aims and scope Submit manuscript

Abstract

Several researches indicate that autonomic nervous system (ANS) dysfunction in patients with schizophrenia. Recently, salivary alpha-amylase (sAA) has been employed as a useful marker for ANS function. We investigated the extent of ANS dysfunction by measuring sAA and heart rate variability (HRV) of 25 patients with schizophrenia compared with controls. Schizophrenia group demonstrated a significant increase in sAA and markedly lower parasympathetic nervous system (PNS) activity in the HRV. However, there were no significant differences between two groups in sympathetic nervous system (SNS) activity. We concluded that PNS might be suppressed and the SNS shows relatively high activity in schizophrenia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Rechlin T, Claus D, Weis M (1994) Heart rate variability in schizophrenic patients and changes of autonomic heart rate parameters during treatment with clozapine. Biol Psychiatry 35:888–892

    Article  CAS  PubMed  Google Scholar 

  2. Okada T, Toichi M, Sakihama M (2003) Influences of an anticholinergic antiparkinsonian drug, parkinsonism, and psychotic symptoms on cardiac autonomic function inschizophrenia. J Clin Psychopharmacol 23:441–447

    Article  CAS  PubMed  Google Scholar 

  3. Bär KJ, Letzsch A, Jochum T, Wagner G, Greiner W, Sauer H (2005) Loss of efferent vagal activity in acute schizophrenia. J Psychiatr Res 39:519–527

    Article  PubMed  Google Scholar 

  4. Conny M, Louis A, Jeroen C, Gerard B, Herman P (1993) Heart rate variability. Ann Intern Med 118:436–447

    Article  Google Scholar 

  5. Moritani T, Hayashi T, Shinohara M, Mimasa F, Masuda I, Nakao K (1995) Sympatho-vagal activities of NIDDM patients during exercise as determined by heart rate spectral analysis. In: Kawamori R, Vranic M, Horton ES, Kubota M (eds) Glucose Fluxes, Exercise and Diabetes. Smith Gordon, London., pp 91–96

    Google Scholar 

  6. Davy KP, DeSouza CA, Jones PP, Seals DR (1998) Elevated heart rate variability in physically active young and older adult women. Clin Sci 94:579–584

    CAS  PubMed  Google Scholar 

  7. Mujica-Parodi LR, Yeragani V, Malaspina D (2005) Nonlinear complexity and spectral analyses of heart rate variability in medicated and unmedicated patients with schizophrenia. Neuropsychobiology 51:10–15

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Matsumoto T, Ushiroyama T, Kimura T, Sakuma K, Moritani T (2007) Therapeutic effects of psychological treatment in the outpatient climacteric clinic evaluated with an index of autonomic nervous system activity. J Jpn Menopause Soc 15:135–145

    Article  Google Scholar 

  9. Ue H, Masuda I, Yoshitake Y, Inazumi T, Moritani T (2000) Assessment of cardiac autonomic nervous activities by means of ECG R–R interval power spectral analysis and cardiac depolarization process. Ann Noninvasive Electrocardiol 5:336–345

    Article  Google Scholar 

  10. Ruschena D, Mullen PE, Burgess P, Cordner SM, Barry-Walsh J, Drummer OH et al (1998) Sudden death in psychiatric patients. Br J Psychiatry 172:331–336

    Article  CAS  PubMed  Google Scholar 

  11. Druss BG, Bradfold DW, Rosenheck RA, Radford MJ, Krumholz HM (2000) Mental disorders and use of cardiovascular procedures after myocardial infarction. JAMA 283:506–511

    Article  CAS  PubMed  Google Scholar 

  12. Hennekens CH, Hennekens AR, Hollar D, Casey DE (2005) Schizophrenia and increased risks of cardiovascular disease. Am Heart J 150:1115–1121

    Article  PubMed  Google Scholar 

  13. Kyunghee L, Jeongeon P, Jeongim C, Chang Gi P (2011) Heart rate variability and metabolic syndrome in hospitalized patients with schizophrenia. J Korean Acad Nurs 41:788–794

    Article  Google Scholar 

  14. Toichi M, Kubota Y, Murai T, Kamio Y, Sakihama M, Toriuchi T et al (1999) The influence of psychotic states on the autonomic nervous system in schizophrenia. Int J Psychophysiol l 31:147–154

    Article  CAS  Google Scholar 

  15. Fujibayashi M, Matsumoto T, Kishida I, Kimura T, Ishii C, Ishii N et al (2009) Autonomic nervous system activity and psychiatric severity in schizophrenia. Psychiatry Clin Neurosci 63:538–545

    Article  PubMed  Google Scholar 

  16. Hempel RJ, Tulen JHM, van Beveren NJM et al (2009) Cardiovascular variability during treatment with haloperidol, olanzapine or risperidone in recent-onset schizophrenia. J Psychopharmacol 23:697–707

    Article  CAS  PubMed  Google Scholar 

  17. Nater UM, Rohleder N, Gaab J, Berger S, Jud A, Kirschbaum C et al (2005) Human salivary alpha-amylase reactivity in a psychosocial stress paradigm. Int J Psychophysiol 55:333–342

    Article  PubMed  Google Scholar 

  18. Nater UM, Rohleder N (2009) Salivary alpha-amylase as a non-invasive biomarker for the sympathetic nervous system: current state of research. Psychoneuroendocrinology 34:486–496

    Article  CAS  PubMed  Google Scholar 

  19. Rohleder N, Nater UM, Wolf JM, Ehlert U, Kirschbaum C (2004) Psychosocial stress-induced activation of salivary alpha-amylase. An indicator of sympathetic activity? Ann N Y Acad Sci 1032:258–263

    Article  CAS  PubMed  Google Scholar 

  20. Gordis EB, Granger DA, Susman EJ, Trickett PK (2006) Asymmetry between salivary cortisol and alpha-amylase reactivity to stress: relation to aggressive behavior in adolescents. Psychoneuroendocrinology 31:976–987

    Article  CAS  PubMed  Google Scholar 

  21. Yamaguchi M, Deguchi M, Wakasugi J, Ono S, Takai N, Higashi T et al (2006) Hand-held monitor of sympathetic nervous system using salivary amylase activity and its validation by driver fatigue assessment. Biosens Bioelectron 21:1007–1014

    Article  CAS  PubMed  Google Scholar 

  22. Thoma MV, Kirschbaum C, Wolf JM, Rohleder N (2012) Acute stress responses in salivary alpha-amylase predict increases of plasma norepinephrine. Biol Psychol 91:342–348

    Article  PubMed  Google Scholar 

  23. Inagaki T, Miyaoka T, Okazaki S, Yasuda H, Kawamukai T, Utani E et al (2010) High salivary alpha-amylase levels in patients with schizophrenia: a pilot study. Prog Neuropsychopharmacol Biol Psychiatry 34:688–691

    Article  CAS  PubMed  Google Scholar 

  24. Yamaguchi M, Kanemori T, Kanemaru M, Takai N, Mizuno Y, Yoshida H (2004) Performance evaluation of salivary amylase activity monitor. Biosens Bioelectron 20:491–497

    Article  CAS  PubMed  Google Scholar 

  25. Yamaguchi M, Wakasugi J, Sakakima J (2008) Competitive and product inhibition-based a-amylase activity analysis method. Clin Biochem 41:325–330

    Article  CAS  PubMed  Google Scholar 

  26. Higashi T, Mizuno Y, Oonishi M, Takeda K, Yamaguchi M. Nonverbal communication tool for children with severe motor and intellectual disabilities using biochemical measurement. In: Medicine and Biology 27th Annual Conference; Sep 1, 2005, Shanghai, China. Abstract NR4:3538

  27. Inagaki T, Ieda M, Yamashia S, Miyaoka T, Horiguchi J (2011) Salivary alpha-amylase reactivity under psycho-physiological stress. A nonverbal communication measurement tool? J Behav Brain Sci 1:12–15

    Article  CAS  Google Scholar 

  28. Nater UM, Rohleder N, Schlotz W, Ehlert U, Kirschbaum C (2007) Determinants of the diurnal course of salivary alpha-amylase. Psychoneuroendocrinology 32:392–401

    Article  CAS  PubMed  Google Scholar 

  29. Noto Y, Sato T, Kudo M, Kurata K, Hirota K (2005) The relationship between salivary biomarkers and state-trait anxiety inventory score under mental arithmetic stress: a pilot study. Anesth Analg 101:1873–1876

    Article  CAS  PubMed  Google Scholar 

  30. Nater UM, Marca RL, Florin L, Moses A, Langhans W, Koller MM et al (2006) Stress-induced changes in human salivary alpha-amylase activity-associations with adrenergic activity. Psychoneuroendocrinology 31:49–58

    Article  CAS  PubMed  Google Scholar 

  31. Akselrod S, Gordon D, Ubel FA, Shannon DC, Berger AC, Cohen RJ (1981) Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science 213:220–222

    Article  CAS  PubMed  Google Scholar 

  32. Pagani M, Lombardi F, Guzzetti S, Rimoldi O, Furlan R, Pizzinelli P et al (1986) Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ Res 59:178–193

    Article  CAS  PubMed  Google Scholar 

  33. Matsumoto T, Miyawaki T, Ue H, Kanda T, Zenji C, Moritani T (1999) Autonomic responsiveness to acute cold exposure in obese and non-obese young women. Int J Obes Relat Metab Disord 23:793–800

    Article  CAS  PubMed  Google Scholar 

  34. Moritani T, Kimura T, Hamada T, Nagai N (2005) Electrophysiology and kinesiology for health and disease. J Electromyogr Kinesiol 15:240–255

    Article  PubMed  Google Scholar 

  35. Takai N, Yamaguchi M, Aragaki T, Eto K, Uchihashi K, Nishikawa Y (2004) Effect of psychological stress on the salivary cortisol and amylase levels in healthy young adults. Arch Oral Biol 49:963–968

    Article  CAS  PubMed  Google Scholar 

  36. van Stegeren A, Rohleder N, Everaerd W, Wolf OT (2006) Salivary alpha amylase as marker for adrenergic activity during stress: effect of beta blockade. Psychoneuroendocrinology 31:137–141

    Article  PubMed  Google Scholar 

  37. Skosnik PD, Chatterton RT Jr, Swisher T, Park S (2000) Modulation of attentional inhibition by norepinephrine and cortisol after psychological stress. Int J Psychophysiol 36:59–68

    Article  CAS  PubMed  Google Scholar 

  38. Shirasaki S, Fujii H, Takahashi M, Takahashi M, Sato T, Ebina M et al (2007) Correlation between salivary alpha-amylase activity and pain scale in patients with chronic pain. Reg Anesth Pain Med 32:120–123

    CAS  PubMed  Google Scholar 

  39. Bär KJ, Boettger MK, Schulz S, Harzendorf C, Agelink MW, Yeragani VK et al (2008) The interaction between pupil function and cardiovascular regulation in patients with acute schizophrenia. Clin Neurophysiol 119:2209–2213

    Article  PubMed  Google Scholar 

  40. Bär KJ, Wernich K, Boettger S, Cordes J, Boettger MK, Löffler S et al (2008) Relationship between cardiovagal modulation and psychotic state in patients with paranoid schizophrenia. Psychiatry Res 157:255–257

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors would like to thank Dr. Akira Nishida (Kaisei Hospital, Izumo, Japan) and our colleagues in the Department of Psychiatry of Shimane University Faculty of Medicine. Part of this work was supported by Grants-in-Aid for Scientific Research on Priority Areas No. 13770544 and 50284047 from the Ministry of Education, Science, Sports and Culture of Japan.

Conflict of interest

All authors declare that they have no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tsuyoshi Miyaoka.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ieda, M., Miyaoka, T., Wake, R. et al. Evaluation of autonomic nervous system by salivary alpha-amylase level and heart rate variability in patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci 264, 83–87 (2014). https://doi.org/10.1007/s00406-013-0411-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00406-013-0411-6

Keywords

Navigation